<?xml version="1.0" encoding="UTF-8"?>

<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher">setsci</journal-id>
   <journal-title-group>
    <journal-title>SETSCI Conference Proceedings</journal-title>
   </journal-title-group>
   <issn publication-format="electronic">2687-5527</issn>
   <publisher>
    <publisher-name>SET Technology</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.36287/setsci.4.9.021</article-id>
   <article-id pub-id-type="publisher-id">a0f19eed-87ba-4fa0-bcec-d0dbb7e59a1b</article-id>
   <title-group>
    <article-title>The Effects of Melatonin Administration on Bone Tissue SIRT1 levels in old Female Rats with Diabetic</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author">
     <name>
      <surname>Ünal</surname>
      <given-names>Ömer</given-names>
     </name>
     <xref ref-type="aff" rid="aff1"/>
    </contrib>
    <contrib contrib-type="author">
     <name>
      <surname>Baltacı</surname>
      <given-names>Saltuk Buğra</given-names>
     </name>
     <xref ref-type="aff" rid="aff1"/>
    </contrib>
    <contrib contrib-type="author">
     <name>
      <surname>Akgün Ünal</surname>
      <given-names>Nilüfer</given-names>
     </name>
     <xref ref-type="aff" rid="aff1"/>
    </contrib>
    <contrib contrib-type="author">
     <name>
      <surname>Mogulkoc</surname>
      <given-names>Rasim</given-names>
     </name>
     <xref ref-type="aff" rid="aff1"/>
    </contrib>
    <contrib contrib-type="author" corresp="yes">
     <name>
      <surname>Baltaci</surname>
      <given-names>Abdulkerim Kasım</given-names>
     </name>
     <xref ref-type="aff" rid="aff1"/>
    </contrib>
   </contrib-group>
   <aff id="aff1">
    <institution>Selcuk University</institution>
   </aff>
   <pub-date date-type="pub">
    <day>23</day>
    <month>12</month>
    <year>2019</year>
   </pub-date>
   <volume>12</volume>
   <fpage>20</fpage>
   <lpage>21</lpage>
   <permissions>
    <copyright-statement>© 2019 SET Technology</copyright-statement>
    <copyright-year>2019</copyright-year>
    <copyright-holder>SET Technology</copyright-holder>
    <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
     <license-p>CC BY 4.0</license-p>
    </license>
   </permissions>
   <abstract>
    <p>The aim of this study was to investigate how melatonin administration  diabetic elderly female  rats affects the levels of bone tissue SIRT1. The study was performed on female aged rats (16 months old) who were provided by The Experimental Medicine Research and Application Center of Selçuk University.  A total of 24 elderly female rats were divided into 4 groups: Group 1. Control, Group 2. Control + Melatonin, Group 3. Diabetes, Group 4. Diabetes + Melatonin. In order to induce diabetes, the animals were intraperitoneally (IP) injected with 40 mg/kg streptozotocin (STZ). The animals were supplemented with 5 mg/kg/day melatonin IP for 4 weeks.  At the end of the study, SIRT1 protein gene expression  were determined by PCR, on bone tissue samples obtained from the  animals  sacrificed  under general anesthesia. In our study, the highest bone tissue SIRT1 expression values were obtained in the diabetes + melatonin group (G4) and the lowest bone SIRT 1 levels were found in the diabetes group (G3). Our results suggest that melatonin supplementation increases bone SIRT1 expression in diabetic elderly female rats.</p>
   </abstract>
   <kwd-group xml:lang="en">
    <kwd>old female rats, diabetes mellitus, bone tissue, melatonin, SIRT1</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>old female rats, diabetes mellitus, bone tissue, melatonin, SIRT1</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <back>
  <ref-list>
   <ref id="ref1">
    <mixed-citation>C. Zhao, G. Liu, Y. Zhang, G. Xu, X. Yi, J. Liang, Y. Yang, J. Liang, C. Ma , Y. Ye, M. Yu, and Qu X, “Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus,” J Clin Lab Anal, 2019, e23112.</mixed-citation>
   </ref>
   <ref id="ref2">
    <mixed-citation>C.E. Murray and C.M. Coleman, “Impact of Diabetes Mellitus on Bone Health,” Int J Mol Sci, 2019, 20(19), pii. E4873.</mixed-citation>
   </ref>
   <ref id="ref3">
    <mixed-citation>M. Bicer, S.B. Baltaci, S. Patlar, R. Mogulkoc and A.K. Baltaci, “Melatonin has a protective effect against lipid peroxidation in the bone tissue of diabetic rats subjected to acute swimming exercise,” Horm Mol Biol Clin Investig, 2018, 34(2), pii. /j/hmbci.2018.34.issue-2.</mixed-citation>
   </ref>
   <ref id="ref4">
    <mixed-citation>S. Yildirimturk, S. Batu, C. Alatli, V. Olgac, D. Firat and Y. Sirin, “The effects of supplemental melatonin administration on the healing of bone defects in streptozotocin-induced diabetic rats,” J Appl Oral Sci, 2016, 24(3):239-249.</mixed-citation>
   </ref>
   <ref id="ref5">
    <mixed-citation>W.L. Zhang, H.Z. Meng, R.F. Yang, M.W. Yang, G.H. Sun, J.H. Liu, P.X. Shi, F. Liu and B. Yang, “Melatonin suppresses autophagy in type 2 diabetic osteoporosis” Oncotarget, 2016, 7(32), 52179-52194.</mixed-citation>
   </ref>
   <ref id="ref6">
    <mixed-citation>W.X. Zhang, B.M. He, Y. Wu, J.F. Qiao and Z.Y. Peng, “Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice,” Life Sci, 2019,217:8-15.</mixed-citation>
   </ref>
   <ref id="ref7">
    <mixed-citation>S.W. Lai, Y.S. Liu, D.Y. Lu and C.F. Tsai, “Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1,” Nutrients, 2019, 11(6), pii. E1343.</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
